NCT03802227View on ClinicalTrials.gov

A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users.

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 22, 2018

Primary Completion Date

December 17, 2019

Study Completion Date

January 3, 2020

Conditions
Moderate to Severe Chronic Pain
Interventions
DRUG

NKTR-181

A combination of NKTR-181 and oxycodone IR placebo

DRUG

Oxycodone IR

A combination of oxycodone IR and NKTR-181 placebo

Trial Locations (1)

23298

Investigator Site - Richmond, Richmond

Sponsors
All Listed Sponsors
lead

Nektar Therapeutics

INDUSTRY